Kabiven (Valine, Alanine, Arginine, Histidine, Isoleucine, Leucine, Methionine, Phenylalanine, Proline, Serin)

The solution delivers a balanced blend of amino acids directly into the bloodstream, supplying substrates for protein synthesis, replenishing nitrogen stores, and supporting metabolic pathways essential for tissue repair and immune function without requiring gastrointestinal absorption.

The prescribed dose of Kabiven is individualized by the treating clinician based on the patient’s nutritional requirements, renal function, and overall clinical condition. Dosage is calculated to meet specific protein and nitrogen targets.

Safety data for Kabiven in pregnancy and lactation are limited. It should only be used if the potential benefit to the mother outweighs any possible risk to the fetus or infant, and the decision must be made by a qualified healthcare professional.

To order Kabiven, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain where applicable), and necessary import documentation.

Kabiven offers a comprehensive profile of essential and non‑essential amino acids in a single formulation, matching the amino acid composition recommended for critically ill patients. Compared with some alternatives that may require mixing multiple solutions, Kabiven simplifies preparation and reduces the risk of incompatibility.

Kabiven should be stored at 2‑8 °C, kept refrigerated, protected from light, and must not be frozen or shaken. Use aseptic technique when preparing the infusion and ensure the container remains sealed until use.

Kabiven is administered intravenously as a solution for injection. It is typically infused through a dedicated IV line, with the rate adjusted according to the patient’s fluid balance, metabolic needs, and clinical monitoring parameters.

Serious risks include anaphylactic reactions, metabolic acidosis, severe hyperosmolarity, and renal impairment. Prompt recognition of these events and immediate medical intervention are essential to mitigate potential harm.

Kabiven should be avoided in patients with known hypersensitivity to any component of the solution, severe renal failure without appropriate dose adjustment, or those with uncontrolled electrolyte disturbances that could be exacerbated by the infusion.